784
Views
8
CrossRef citations to date
0
Altmetric
Co-Morbidities

Cardioselective Beta-Blocker Treatment of Hypertension in Patients with Asthma: When Do Benefits Outweigh Risks?

, Pharm.D., , Pharm.D. & , M.D., F.A.C.C.
Pages 947-951 | Published online: 13 Sep 2012

References

  • American Heart Association. Available at: www.heart.org/HEARTORG/conditions/HighBloodPressure/About-High-Blood-Pressure. Accessed August 12, 2011.
  • Expert Panel Report 3: guidelines for the diagnosis and management of asthma. NIH Publication No. 08-4051. Bethesda: National Institutes of Health, 2007.
  • Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 2002; 137:715–725.
  • Salpeter S, Ormiston T, Salpeter E. Cardioselective beta blockers for reversible airway disease. Cochrane Database Syst Rev 2002; (4):CD002992.
  • Chafin CC, Soberman JE, Demirkan K, Self T. Beta-blockers after myocardial infarction: do benefits ever outweigh risks in asthma. Cardiology 1999; 92:99–105.
  • Self T, Soberman JE, Bubla JM, Chafin CC. Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks? J Asthma 2003; 40:839–845.
  • Lindholm LH, Carlberg B, Sammuelsson O. Should beta-blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366:1545–1553.
  • Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J. Beta-blockers for hypertension. Cochrane Database Syst Rev 2007; (1):CD002003.
  • McNeill RS, Ingram CG. Effect of propranolol on ventilatory function. Am J Cardiol 1966; 18:473–475.
  • Raine JM, Palazzo MG, Kerr JH, Sleight P. Near fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane. BMJ 1981; 282:548–549.
  • Williams IP, Millard FJC. Severe asthma after inadvertent ingestion of oxprenolol. Thorax 1980; 35:160.
  • Harries AD. Beta blockade in asthma. BMJ 1981; 282:1321.
  • Fraunfelder FT, Barker AF. Respiratory effects of timolol. N Engl J Med 1984; 311:1441.
  • Odeh M, Oliven A, Bassan H. Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient. J Fam Pract 1991; 32:97–98.
  • Wilcox PG, Ahmad D, Darke AC, Parsons J, Carruthers SG. Respiratory and cardiac effects of metoprolol and bevantolol in patients with asthma. Clin Pharmacol Ther 1986; 39:29–34.
  • Formgren H. The effect of metoprolol and practolol in lung function and blood pressure in hypertensive asthmatics. Br J Clin Pharmacol 1976; 3:2007–2014.
  • Lawrence DS, Sahay JN, Chatterjee SS, Cruick JM. Asthma and beta-blockers. Eur J Clin Pharmacol 1982; 22:501–509.
  • Jackson SH, Beevers DG. Comparison of the effects of single dose atenolol and labetalol on airways obstruction in patients with hypertension and asthma. Br J Clin Pharmacol 1983; 15:553–556.
  • Krauss S, Spitz E, Drauss A, Grizotzki B, Clement S. Treatment of hypertension in mild asthmatic patients with atenolol. Angiology 1984; 35:773–778.
  • Chatterjee SS. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. J Cardiovasc Pharmacol 1986; 8(Suppl. 11):S74–S77.
  • Van Zyl AI, Jennings AA, Bateman ED, Opie LH. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. Chest 1989; 95:209–213.
  • Fogari R, Zoppi A, Tettamanti F, Poletti L, Rizardi G, Fiocchi G. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease. Cardiovasc Drugs Ther 1990; 4:1145–1150.
  • Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318:1730–1737.
  • Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind placebo-controlled, randomized trials. Circulation 1998; 98:1184–1191.
  • Dart RA, Gollub S, Lazar J, Nair C, Schroeder D, Woolf SH. Treatment of systemic hypertension in patients with pulmonary disease: COPD and asthma. Chest 2003; 123:222–243.
  • Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN; American Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011; 21:593–646.
  • American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine; Society for Vascular Surgery, Fleischmann KE, Beckman JA, Buller CE, Calkins H, Fleisher LA, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Robb JF, Valentine RJ. ACCF/AHA focused update on perioperative beta blockade. J Am Coll Cardiol 2009; 54:2102–2128.
  • Armario P, Hernandez del Rey R, Pardell H. Adverse effects of direct-acting vasodilators. Drug Saf 1994; 11:80–85.
  • Self T, Rogers ML, Mancell J, Soberman JE. Carvedilol therapy after cocaine-induced myocardial infarction in patients with asthma. Am J Med Sci 2011; 342:56–61.
  • Lipworth BJ, Williamson PA. Think the impossible: beta-blockers for treating asthma. Clin Sci 2010; 118:115–120.
  • Epstein PE. Fresh air and beta-blockade. Ann Intern Med 2002; 137:766–767.
  • Frishman WH, Saunders E. Beta-adrenergic blockers. J Clin Hypertens 2011; 13:649–653.
  • Nolte H, Neeper-Christensen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med 2006; 100:354–362.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.